Stockscreener 앱 받기
328.20
7.67%
-27.28
전일 마감가:
$355.48
열려 있는:
$351.79
하루 거래량:
1.51M
Relative Volume:
1.78
시가총액:
$23.10B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
43.87
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
-8.39%
1개월 성능:
-3.59%
6개월 성능:
+38.68%
1년 성능:
+17.59%
1일 변동 폭
$327.97
$351.79
1주일 범위
$327.97
$386.00
52주 변동 폭
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
328.20 | 23.10B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
Is West Pharmaceutical Services Inc (WST) a Bargain After 7.7% D - GuruFocus
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - Yahoo Finance UK
West Pharmaceutical Services, Inc. (WPS) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. (WPS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Slides as Investors Digest a Post-Earnings Surge - Quiver Quantitative
West Pharmaceutical Services Q2 2026 Earnings: Revenue, Net Income, and Financial Highlights - Minichart
Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView
WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook - Yahoo Finance
West Pharmaceutical beats 2Q26 estimates, raises full-year sales and EPS guidance. - Pluang
West Pharmaceutical Delivers Another BeatBut The Real Story Is The Mix Shift (NYSE:WST) - Seeking Alpha
Sei Investments Co. Has $132.65 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical: Q2 Earnings Snapshot - theheraldreview.com
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical stock trades steady as recent earnings highlight margin resilience - Ad-hoc-news.de
West Pharmaceutical Services, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:WST) 2026-07-24 - Seeking Alpha
West Pharma Sees 3Q Net Sales $820M-$835M >WST - Moomoo
West Pharmaceutical Services Q2 Earnings Call Highlights - MarketBeat
West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharma Sees 3Q Adj EPS $2.14-Adj EPS $2.24 >WST - Moomoo
West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical (WST) Receives Strong Outlook Amidst Quarterly Performance - GuruFocus
West Pharmaceutical Services, Inc. (WPS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
West Pharmaceutical Services Inc 2Q 2026: Revenue $872.3M, EPS $2.15— 10-Q Summary - TradingView
[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report - Stock Titan
West Pharmaceutical Services, Inc. (WPS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharma says sterile packaging upgrades fuel demand for high-value plastics - Plastics News
West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ... - Yahoo Finance
West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Hig - GuruFocus
WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth - TradingView
West Pharmaceutical Services (WST) Reports Strong Q2 2026 Earnin - GuruFocus
West Pharma raises profit forecast on strong demand for injectable drug components - 1470 & 100.3 WMBD
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026. - marketscreener.com
West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - Benzinga
West Pharmaceutical Services (NYSE:WST) Issues Earnings Results - MarketBeat
West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Why is West Pharmaceutical Services stock surging today? - Investing.com
West Pharmaceutical Services (NYSE:WST) Hits New 12-Month High After Earnings Beat - MarketBeat
Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook - Investing.com
West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call - Benzinga
West Pharmaceutical Services Releases Q2 2026 Financial Results - AlphaStreet
Is West Pharmaceutical Services Inc (WST) Undervalued After Q2 E - GuruFocus
Q2 2026 West Pharmaceutical Services Inc Earnings Call Transcript - GuruFocus
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars - Barchart.com
West Pharmaceutical Services (NYSE:WST) Updates FY 2026 Earnings Guidance - MarketBeat
West Pharmaceutical Services (NYSE:WST) Releases Q3 2026 Earnings Guidance - MarketBeat
Form 8-K WEST PHARMACEUTICAL SERV For: Jul 23 - StreetInsider
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.76%
자본화:
|
볼륨(24시간):